(Q39437813)

12 September 2017

Oral contraceptives and hepatitis. A report from the Boston Collaborative Drug Surveillance Program, Boston University Medical Center (English)

1 reference

12 September 2017

1 reference

2

1 reference

12 September 2017

A S Morrison

1

1 reference

PubMed ID

68236

12 September 2017

H W Ory

series ordinal

3

1 reference

PubMed ID

68236

12 September 2017

language of work or name

English

0 references

publication date

1 May 1977

1 reference

12 September 2017

1 reference

12 September 2017

1

1 reference

12 September 2017

8022

1 reference

12 September 2017

1142-1143

1 reference

Hepatic effects of oral contraceptives

12 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2877%2992397-2

Crossref

reference URL

inferred from DOI database lookup

7 January 2021

based on heuristic

Comprehensive drug surveillance

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2877%2992397-2

Crossref

reference URL

inferred from DOI database lookup

7 January 2021

based on heuristic

Disease of the digestive system. Drugs and the liver.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2877%2992397-2

Crossref

reference URL

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0140-6736(77)92397-2

1 reference

12 September 2017

1 reference

PubMed ID

68236